Clinical Trials Browser

Phase 1/2 × trastuzumab deruxtecan × Other solid neoplasm × Clear all

NCT07157956 2025-09-05

CVL006-T1002

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06525298 2024-09-19

EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor